Iltaqa' ma' Jinan Jianfeng Chemical F'CPHI India 2026 - Booth 2M57
Ħalli messaġġ
Jinan Jianfeng Chemical Co., Ltd tistieden kordjalment kumpaniji farmaċewtiċi, distributuri, xerrejja, u sħab industrijali minn madwar id-dinja biex jattendu l-wirja CPHI Indja 2026. Aħna ħerqana li niltaqgħu miegħek hemmhekk.
Hawn taħt hawn l-informazzjoni tal-wirja:
Avveniment: 2026 CPHI INDIA
Dati: 23–25 ta’ Novembru, 2026
Post: Ashbomi International Convention Centre (IICC), Devakha, New Delhi, l-Indja
Kabina Nru. 2M57
Għaliex Iltaqa' ma' Jianfeng f'CPHI India 2026?
CPHI India 2026 iservi bħala pjattaforma ta 'netwerking vitali għal kumpaniji farmaċewtiċi, distributuri, timijiet ta' akkwist, u fornituri tal-materja prima. Il-wirja 2026 se tiffoka fuq soluzzjonijiet relatati ma 'materja prima farmaċewtika, kimiċi, u formulazzjonijiet.
Il-portafoll tal-prodotti tagħna jinkludi: Intermedji farmaċewtiċi, Ingredjenti farmaċewtiċi attivi (APIs), Kimiċi fini, Ingredjenti kożmetiċi
Bħala amaterja prima farmaċewtikafornitur, il-kumpanija se tniedi prodotti ġodda fl-2026, bħall-komposti sintetiċi SLU-PP-332, SLU-PP-915, u PP-405. Jekk inti interessat, jekk jogħġbok tħossok liberu li tikkuntattja lill-istaff tekniku tagħna biex tiddiskuti dawn il-prodotti.
Bħala aintermedji farmaċewtiċimanifattur, Jinan Jianfeng Chemical Co., Ltd. jesporta diversi intermedji farmaċewtiċi lejn l-Indja is-sena-tunda. Hawn taħt hawn għażla tal-linji ta 'prodotti intermedji tal-kumpanija.
| Zanubrutinib Intermedju | Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-2-(4-phenoxyphenyl)-7-(4-piperidinyl)-, (7S)- | 1633352-71-2 |
| Aċidu butanjojku, 2,3-bis(benzoyloxy)-, (2R,3R)-, komp. bi (7S)-4,5,6,7-tetrahydro-2-(4-phenoxyphenyl)-7-(4-piperidinyl)pirazolo[1,5-a]pyrimidine-3-carboxamide (1:2) | 2190507-22-1 | |
| Apixaban intermedju | 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester | 503614-91-3 |
| 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)aċetat tal-etil | 27143-07-3 | |
| 3-Kloro-1-(4-nitrofenil)-5,6-dihydropyridin-2(1H)-one | 536760-29-9 | |
| 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | 545445-44-1 | |
| 3-Morpholino-1-(4-nitrofenil)-5,6-dihydropyridin-2(1H)-one | 503615-03-0 | |
| etil 1-(4-methoxyphenyl)-6-(4-nitrofenil)-7-oxo-4,5,6,7-tetrahydro-1H-pirazolo[3,4-c]piridin-3-karboxilat | 536759-91-8 | |
| etil 6-(4-aMinophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503615-07-4 | |
| 1-(4-AMinofenil)-5,6-diidro-3-(4-Morpholinyl)-2(1h)-piridinone | 1267610-26-3 | |
| Etil (2Z)-kloro[(4-metossifenil)idrazono]etanoat | 473927-63-8 | |
| Lurasidone intermedju | (1R,2R)-(-)-1,2-Cyclohexanedicarboxylic acid | 46022-05-3 |
| (1R,2R)-1,2-Cyclohexanedimthanol | 65376-05-8 | |
| (R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane | 186204-35-3 | |
| (3aR,7aR)-4'-(1,2-Benzisothiazol-3-yl)octahydrospiro[2H-isoindole-2,1'-piperazinjuM] Methanesulfonate | 186204-37-5 | |
| (3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione | 14805-29-9 | |
| 3-(1-Piperazinyl)-1,2-benzisothiazole | 87691-87-0 | |
| Peramivir intermedju | (3aR,4R,6S,6aS)-4-[[(1,1-DiMethylethoxy)carbonyl]aMino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-6-carboxylicAcid | 229613-93-8 |
| 1H-1,2,4-Triazole-1-carboximidamide hydrochloride | 19503-26-5 | |
| (1S,2S,3S,4R)-Metil 3-((S)-1-aMino-2-ethylbutyl)-4-(tert-butoxicarbonylaMino)-2-hydroxycyclopentanecarboxylate | 316173-29-2 | |
| 4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-cyclopentene-1-carboxylic acid metil ester | 168683-02-1 | |
| 2-Methylpropan{-2-amminju (3ar,4R,6s,6as)-4-((tert-butoxicarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4h-cyclopenta[d]isoxaboxylate-6-isoxazoylate | 316173-28-1 | |
| Selpercatinib intermedju | 6-bromo-4-metossipirazolo[1,5-a]piridin-3-karbonitrile | 1207836-10-9 |
| 3,5-Bis(trifluorometil)benzonitrile | 27126-93-8 | |
| 4-(6-Fluoropyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pirazolo[1,5-a]pyridine-3-carbonitrile | 2222653-74-7 |
Qed tfittex Fornitur Affidabbli tal-Materja Prima Farmaċewtika?
Iltaqa' ma' Jianfeng f'CPHI India 2026, Booth 2M57.
23–25 ta’ Novembru, 2026|IICC, Yashobhoomi, New Delhi, l-Indja
Skeda Laqgħa jew Itlob Konsultazzjoni dwar il-Prodott: info@pharmachemm.com sales01@pharmachemm.com
